Elizabeth Lamont is an Oncology physician affiliated with Dana-Farber Cancer Institute. OpenAlex indexes 94 publications with 5,247 citations (h-index 35).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingNIH funding
6 NIH research awards on record, funded 2004–2014 per NIH RePORTER. The latest:
- Comparative Effectiveness of Treatment Regimens in Lung Cancer
Harvard Medical School
FY2014$211,875R21AG047175 - Population-Based Assessment of Cancer Trial Generalizability in the Elderly
Harvard Medical School
FY2012$362,337R01CA132900 - Do Medicare Claims Measure Cancer Relapse Patients: An External Validation Study
Harvard Medical School
FY2012$221,198R21CA155351
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Kenneth Anderson, MD
Dana-Farber Cancer Institute
Frank Hodi, MD
Dana-Farber Cancer Institute
Paul Richardson, MD
Dana-Farber Cancer Institute
Toni Choueiri, MD
Dana-Farber Cancer Institute
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”